tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vik Chopra, 43 are a HOLD (51.19%), 41 are a BUY (48.81%).
Analyst Vik Chopra, currently employed at BMO, carries an average stock price target met ratio of 61.45% that have a potential upside of 20.07% achieved within 106 days. Previously, Vik Chopra worked at WELLS FARGO.
Vik Chopra’s has documented 166 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVST, Envista Holdings Corp.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 2/27/2026. The price target of $13 was fulfilled within 7 days with a profit of $1.68 (11.44%) receiving and performance score of 16.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2025
$36
$18.23 (102.59%)
$45
1 months 2 days ago
(02-Sep-2026)
0/2 (0%)
$15.8 (78.22%)
Buy Since 08-May-2026
$33
$15.23 (85.71%)
$39
1 months 2 days ago
(02-Sep-2026)
0/3 (0%)
$12.8 (63.37%)
Buy Since 03-Oct-2024
$47
$29.23 (164.49%)
$55
1 months 2 days ago
(02-Sep-2026)
0/3 (0%)
$26.8 (132.67%)
Buy Since 23-Feb-2024
$45
$27.23 (153.24%)
1 months 17 days ago
(17-Aug-2026)
0/4 (0%)
$20.26 (81.89%)
Buy Since 06-Jan-2026
$40
$22.23 (125.10%)
$39
1 months 28 days ago
(06-Aug-2026)
0/6 (0%)
$13.69 (52.03%)
Which stock is Vik Chopra most bullish on?
Which stock is Vik Chopra most reserved on?
What Year was the first public recommendation made by Vik Chopra?
